Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Database
Language
Document Type
Year range
1.
Pflege Z ; 76(6): 30-33, 2023.
Article in German | MEDLINE | ID: covidwho-2323292
2.
Dtsch Med Wochenschr ; 146(21): e113, 2021 Oct.
Article in German | MEDLINE | ID: covidwho-1532186
3.
Dtsch Med Wochenschr ; 146(21): 1399-1404, 2021 10.
Article in German | MEDLINE | ID: covidwho-1475522

ABSTRACT

Most people recover completely after an acute infection with the novel corona virus SARS-CoV2. But some people continue to experience symptoms after their recovery. This phenomenon is called post-acute or long-COVID (from week 4 after the infection up to week 12) and persistent post-COVID (symptoms for effects that persist 12 or more weeks after onset). The exact processes that cause long COVID remain unknown.Most of those patients suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise. Today, 18 months after the first infections in Europe we have access to the first practical guidelines for the long-/post-COVID syndrome. Further on first prospective studies analysing the incidence of post-COVID are now available.In this review we will discuss some questions about treatment and follow up of patients suffering from pulmonary sequelae after their COVID-19 infection, based on the actual literature.


Subject(s)
COVID-19/complications , COVID-19/epidemiology , COVID-19/physiopathology , COVID-19/therapy , Europe , Humans , Incidence , Practice Guidelines as Topic , Post-Acute COVID-19 Syndrome
4.
Pneumologie ; 75(11): 869-900, 2021 Nov.
Article in German | MEDLINE | ID: covidwho-1392935

ABSTRACT

The German Society of Pneumology initiated the AWMFS1 guideline Post-COVID/Long-COVID. In a broad interdisciplinary approach, this S1 guideline was designed based on the current state of knowledge.The clinical recommendation describes current post-COVID/long-COVID symptoms, diagnostic approaches, and therapies.In addition to the general and consensus introduction, a subject-specific approach was taken to summarize the current state of knowledge.The guideline has an expilcit practical claim and will be continuously developed and adapted by the author team based on the current increase in knowledge.


Subject(s)
COVID-19 , Pulmonary Medicine , COVID-19/complications , Consensus , Humans , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL